Browsing by Author Androulakis, N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 6 of 6
TitleAuthor(s)Issue date???itemlist.???
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursBozionelou, V.; Vamvakas, L.; Pappas, P.; Agelaki, S.; Androulakis, N.; Kalykaki, A.; Nikolaidou, M.; Kentepozidis, N.; Giassas, S.; Marselos, M.; Georgoulias, V.; Mavroudis, D.24-Nov-2015-
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMavroudis, D.; Pappas, P.; Kouroussis, C.; Kakolyris, S.; Agelaki, S.; Kalbakis, K.; Androulakis, N.; Souglakos, J.; Vardakis, N.; Nikolaidou, M.; Samonis, G.; Marselos, M.; Georgoulias, V.24-Nov-2015-
Formation of platelet-activating factor and its bioactive analogues upon Cu2+ induced LDL oxidationTsoukatos, D. C.; Androulakis, N.; Tselepis, A. D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidationAndroulakis, N.; Durand, H.; Ninio, E.; Tsoukatos, D. C.24-Nov-2015-
Platelet-activating factor and oxidized LDLAndroulakis, N.; Aronis, P.; Tsoukatos, D. C.24-Nov-2015-
Substantial contribution of C16 : 0 PAF on the PAF-like bioactivity formed in oxidized LDLAndroulakis, N.; Ninio, E.; Tsoukatos, D. C.24-Nov-2015-